Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,141 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $395.08 | 4 | $0 (2019) |
| Genentech USA, Inc. | $195.07 | 2 | $0 (2018) |
| GENZYME CORPORATION | $193.75 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2019) |
| Exelixis Inc. | $118.22 | 1 | $0 (2019) |
| Daiichi Sankyo Inc. | $113.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.40 | 1 | Daiichi Sankyo Inc. ($113.40) |
| 2022 | $123.95 | 1 | GENZYME CORPORATION ($123.95) |
| 2019 | $412.86 | 4 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2018 | $274.46 | 3 | Merck Sharp & Dohme Corporation ($189.22) |
| 2017 | $215.85 | 2 | Genentech USA, Inc. ($109.83) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $123.95 | General |
| Category: Hematology | ||||||
| 11/14/2019 | GENZYME CORPORATION | CABLIVI (Drug) | Food and Beverage | In-kind items and services | $69.80 | General |
| Category: RARE BLOOD DISORDERS | ||||||
| 08/29/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $118.22 | General |
| Category: Oncology | ||||||
| 08/21/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $99.84 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/18/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $85.24 | General |
| Category: BioOncology | ||||||
| 06/27/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $98.24 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $90.98 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $109.83 | General |
| 06/22/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $106.02 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 19 | $6,270 | $509.14 |
| 2021 | 9 | 385 | 712 | $192,141 | $19,837 |
| 2020 | 9 | 231 | 331 | $67,847 | $9,432 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 11 | 19 | $6,270 | $509.14 | 8.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 140 | 226 | $74,013 | $6,610 | 8.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 33 | 158 | $28,662 | $3,548 | 12.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2021 | 38 | 48 | $23,673 | $3,053 | 12.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2021 | 20 | 75 | $24,238 | $2,480 | 10.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2021 | 40 | 71 | $11,844 | $1,498 | 12.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 38 | 43 | $10,192 | $1,158 | 11.4% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2021 | 12 | 12 | $5,100 | $588.24 | 11.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2021 | 45 | 55 | $10,882 | $493.34 | 4.5% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2021 | 19 | 24 | $3,537 | $408.93 | 11.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 79 | 119 | $31,773 | $3,621 | 11.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2020 | 21 | 25 | $10,200 | $1,671 | 16.4% |
| 88360 | Microscopic genetic analysis of tumor | Facility | 2020 | 15 | 47 | $9,494 | $1,619 | 17.1% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 22 | 27 | $3,645 | $776.55 | 21.3% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 19 | 25 | $3,375 | $576.31 | 17.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2020 | 21 | 28 | $1,596 | $575.29 | 36.0% |
| 88108 | Cell examination of specimen | Facility | 2020 | 16 | 17 | $1,717 | $291.70 | 17.0% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2020 | 24 | 26 | $5,044 | $240.21 | 4.8% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2020 | 14 | 17 | $1,003 | $60.85 | 6.1% |
About Dr. Khaled Sarah, M.D
Dr. Khaled Sarah, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1598996282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khaled Sarah, M.D has received a total of $1,141 in payments from pharmaceutical and medical device companies, with $113.40 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,141).
As a Medicare-enrolled provider, Sarah has provided services to 627 Medicare beneficiaries, totaling 1,062 services with total Medicare billing of $29,779. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology, Anatomic Pathology & Clinical Pathology
- Location El Paso, TX
- Active Since 07/29/2009
- Last Updated 10/20/2015
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1598996282
Products in Payments
- KEYTRUDA (Biological) $395.08
- TAGRISSO (Drug) $125.00
- CABLIVI (Biological) $123.95
- Cabometyx (Drug) $118.22
- Enhertu (Drug) $113.40
- Perjeta (Biological) $85.24
- CABLIVI (Drug) $69.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in El Paso
Dr. Cesar Abbud-Mendez, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $1,844
Arturo Vargas, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $1,023
Hector Zepeda, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $580.04
Ruben Delgado, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $419.73
Dr. Mohamad Hakim, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $386.65
Mariano Allen, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $305.92